Granulomatous Inflammation in Tuberculosis and Sarcoidosis: Does the Lymphatic System Contribute to Disease?
Karen C PattersonChristophe J QuevalMaximiliano G GutierrezPublished in: BioEssays : news and reviews in molecular, cellular and developmental biology (2019)
A striking and unexplained feature of granulomatous inflammation is its anatomical association with the lymphatic system. Accumulating evidence suggests that lymphatic tracks and granulomas may alter the function of each other. The formation of new lymphatics, or lymphangiogenesis, is an adaptive response to tumor formation, infection, and wound healing. Granulomas also may induce lymphangiogenesis which, through a variety of mechanisms, could contribute to disease outcomes in tuberculosis and sarcoidosis. On the other hand, alterations in lymph node function and lymphatic draining may be primary events which attenuate the risk and severity of granulomatous inflammation. This review begins with an introduction of granulomatous inflammation and the lymphatic system. A role of the lymphatic system in tuberculosis and sarcoidosis is then hypothesized. With a focus on lymphangiogenesis in these diseases, and on the potential for this process to promote dissemination, parallels are established with the well-established role of lymphangiogenesis in tumor biology.
Keyphrases
- lymph node
- oxidative stress
- mycobacterium tuberculosis
- interstitial lung disease
- neoadjuvant chemotherapy
- sentinel lymph node
- wound healing
- deep learning
- radiation therapy
- type diabetes
- systemic sclerosis
- climate change
- human immunodeficiency virus
- metabolic syndrome
- skeletal muscle
- weight loss
- glycemic control
- idiopathic pulmonary fibrosis